Levetiracetam Treatment of Tardive Dyskinesia

Completed · Phase 3 · Has a placebo group

Conditions studied: Tardive Dyskinesia

In brief

This is a placebo-controlled study designed to learn if levetiracetam is effective for tardive dyskinesia.

Key facts

Study ID

NCT00291213

Run by

Yale University

People needed

50

Last updated by the study team

2014-06-06

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Connecticut Mental Health Center — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.